|
|
|
Volumn 11, Issue 8 Suppl 8, 1997, Pages 42-45
|
|
Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
DRUG DERIVATIVE;
GRANULOCYTE COLONY STIMULATING FACTOR;
PACLITAXEL;
TAXOID;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MULTICENTER STUDY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
REVIEW;
SURVIVAL RATE;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INFUSIONS, INTRAVENOUS;
LUNG NEOPLASMS;
MULTICENTER STUDIES;
PACLITAXEL;
RANDOMIZED CONTROLLED TRIALS;
REMISSION INDUCTION;
SURVIVAL RATE;
TAXOIDS;
|
|
EID: 0031202568
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (22)
|
